Natural compounds are identified as a promising new direction for ferroptosis-targeting drugs, but the abstract indicates the mechanistic basis for how these compounds interact with ferroptosis pathways remains unexplored. This knowledge gap limits rational drug design approaches. Gap type: open_question Source paper: Broadening horizons: the multifaceted role of ferroptosis in breast cancer. (2024, Frontiers in immunology, PMID:39664391)
Landscape Summary: How do natural compounds mechanistically target ferroptosis pathways for breast cancer treatment? is a 0.75 priority gap in pharmacology. It has 0 linked hypotheses with average composite score 0.000. Status: open.
Colonna, Sevlever, et al. (TREM2 biology)
How do natural compounds mechanistically target ferroptosis pathways for breast cancer treatment? — INVOKE-2 (completed)
No hypotheses linked to this gap yet.
No knowledge graph edges recorded
No activity recorded yet.
No discussions yet. Be the first to comment.
Create sub-tasks to investigate specific aspects of this gap: